A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01)
Patent
CA 2100329
Methods for treating TNF mediated diseases are provided. The methods comprise administering to patients in need there-of of therapeutically effective amount of a TNF inhibitor. In a preferred embodiment, the TNF inhibitor is selected from the group consisting of 30kDa TNF inhibitor, C105-PEG 3400 db and 40kDa TNF inhibitor, and the 40kDa TNF inhibitor is select-ed from the group consisting of full-length 40kDa TNF inhibitor, 40kDa TNF inhibitor .DELTA.51 and 40kDa TNF inhibitor .DELTA.53. A preferred method for producing the TNF inhibitors is by recombinant DNA technology.
Carmichael David F.
Kohno Tadahiko
Russell Deborah
Smith Christopher G.
Thompson Robert C.
Amgen Inc.
Smart & Biggar
Synergen Inc.
LandOfFree
Methods for treating tumor necrosis factor mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating tumor necrosis factor mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating tumor necrosis factor mediated diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2089058